Discontinued — last reported Q4 '25
Enbridge Interest Paid remained flat by 0.0% to $1.23B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 19.1%, from $1.03B to $1.23B. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 19.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | 2.4B | 2.9B | 3.4B | 4.1B | 4.9B |
| YoY Change | — | +20.3% | +15.8% | +22.3% | +19.1% |